A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...

PORTLAND, Oregon — San Franciscans have a new option when it comes to HIV pre-exposure prophylaxis: PrEP on-demand. "It's a great option for people who are having a little less frequent sex and are ...

Up until 2012, there was only one way to protect yourself from acquiring the Human Immunodeficiency Virus (HIV) from sex: wearing condoms. While condoms are still a great preventive tool, there’s ...

PrEP could soon become a monthly pill to prevent HIV infection, rather than a daily pill. Pharmaceutical company Merck has released data from the second phase of trials into its antiretroviral drug ...

When PrEP (pre-exposure prophylaxis), a drug that prevents HIV infection, was first approved by the FDA in 2012, it was a medical breakthrough that promised to drastically reduce HIV transmission.

Worldwide, nearly half of new HIV infections among adults in 2019 occurred in women. Yet a long list of obstacles has kept many women from taking advantage of medicine that can prevent an HIV ...

When the antiretroviral regimen known as pre-exposure prophylaxis, or PrEP, was launched nearly a decade ago, patients were suddenly able to achieve near-complete protection against contracting HIV by ...